Identification | More | [Name]
4-BENZYLOXYCARBONYLAMINO-PIPERIDINE-1,4-DICARBOXYLIC ACID MONO-TERT-BUTYL ESTER | [CAS]
288154-16-5 | [Synonyms]
Z-PIP(BOC)-OH 1-BOC-4-N-CBZ-AMINOISONIPECOTIC ACID Z-4-AMINO-1-BOC-PIPERIDINE-4-CARBOXYLIC ACID Cbz-4-amino-1-Boc-piperidine-4-carboxylic acid 1-BOC-4-N-CBZ-AMINOPIPERIDINE-4-CARBOXYLIC ACID 1-Boc-4-(Cbz-amino)piperidine-4-carboxylic Acid 4-(Cbz-aMino)-1-Boc-piperidine-4-carboxylic acid N-BOC-4-(N-CBZ-AMINO) PIPERIDINE-4-CARBOXYLIC ACID 1-N-BOC-4-N-CBZ-AMINO-PIPERIDINE-4-CARBOXYLIC ACID 4-(BENZYLOXYCARBONYLAMINO)-1-(TERT-BUTOXYCARBONYL)PIPERIDINE-4-CARBOXYLIC ACID 4-BENZYLOXYCARBONYLAMINO-PIPERIDINE-1,4-DICARBOXYLIC ACID MONO-TERT-BUTYL ESTER 4-[(Benzyloxycarbonyl)amino]piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 1-[(2-methylpropan-2-yl)oxycarbonyl]-4-(phenylmethoxycarbonylamino)piperidine-4-carboxylic Acid 1,4-Piperidinedicarboxylic acid, 4-[[(phenylmethoxy)carbonyl]amino]-, 1-(1,1-dimethylethyl) ester | [Molecular Formula]
C19H26N2O6 | [MDL Number]
MFCD02683056 | [Molecular Weight]
378.42 | [MOL File]
288154-16-5.mol |
Safety Data | Back Directory | [Symbol(GHS) ]
 GHS07 | [Signal word ]
Warning | [Hazard statements ]
H315-H319-H335 | [Precautionary statements ]
P261-P305+P351+P338 | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . | [HS Code ]
29333990 |
Hazard Information | Back Directory | [Chemical Properties]
White powder | [Synthesis]
To a solution of compound 2-c (0.50 g, 2.05 mmol) in tetrahydrofuran (THF, 4 mL) was added an aqueous sodium hydroxide solution (0.17 g, 4.30 mmol, 2.10 equiv, 4 mL). The reaction mixture was cooled to 0°C. Benzyl chloroformate (0.32 mL, 2.25 mmol, 1.10 eq.) was slowly added dropwise followed by stirring at room temperature for 24 hours. Upon completion of the reaction, the reaction mixture was washed with ether, then the pH of the aqueous layer was adjusted to 2.5 with 1N hydrochloric acid and extracted with ethyl acetate. The organic layers were combined, dried with anhydrous magnesium sulfate, and concentrated under reduced pressure to afford 4-benzyloxycarbonylaminopiperidine-1,4-dicarboxylic acid mono-tert-butyl ester as a white solid (0.55 g, 71% yield), which was used directly in the next step of the reaction.1H-NMR (CDCl3) δ: 7.29-7.39 (m, 5H), 5.10 (s, 2H), 3.84 (bs, 2H). 3.05-3.15 (m, 2H), 1.95-2.12 (m, 4H), 1.45 (s, 9H). | [References]
[1] Patent: US2010/168421, 2010, A1. Location in patent: Page/Page column 7 [2] Patent: WO2008/150089, 2008, A1. Location in patent: Page/Page column 15 |
|
Company Name: |
JSK Chemicals
|
Tel: |
+919879767970 |
Website: |
www.jskchemicals.com |
Company Name: |
J S LABS
|
Tel: |
+91-7330612784 |
Website: |
www.jslaboratories.com |
|